Fundz
New|Fundz now works inside Claude2 min

Timing. Relevance. Relationships.

Fundz is the only platform that reads more than a dozen real‑time signals all day, every day, so you know about new funding, new executives and new contracts within minutes of them happening, not days or weeks later like the databases you’re used to. It then combines the signals on each company, scores every company against what you offer, and weaves in your own network, so you discover new accounts first and work existing ones better.

Each morning you get the ones worth your time right now: who to reach, why now, and who you already know there. Now it answers in Claude too: ask for today’s leads, then write the note in the same window.

Trusted by

OracleSnowflakeCloudflareLinkedInGoogleSalesforce
4.8/5 on G2· Since 2015

Alaunos Therapeutics acquires Velaris Therapeutics

PUBLIC · TCRTOct 13, 2026

Acquiring Company

Alaunos Therapeutics

Acquired Company

Velaris Therapeutics

HoustonBeratBiotechnologyHealth CareBiotechnologyHealth CareTherapeutics

Description

Alaunos Therapeutics, Inc. has successfully acquired Velaris Therapeutics. This acquisition enhances Alaunos's capabilities in developing cutting-edge therapies for cancer. The integration of Velaris is expected to accelerate innovation and improve patient outcomes in the oncology space.

Company Information

Company

Alaunos Therapeutics

Location

Houston, Texas, United States

About

A clinical-stage oncology-focused cell therapy company. Alaunos is currently exploring strategic alternatives, including but not limited to acquisitions, mergers, reverse mergers, sale of assets, strategic partnerships, capital raises, or other transactions.

Fundz sees it the moment Alaunos Therapeutics makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Predictive Intelligence
Strategic

ML-powered predictions for Alaunos Therapeutics's next move

Learn about Strategic plan

Frequently asked

Who acquired Velaris Therapeutics?

Velaris Therapeutics was acquired by Alaunos Therapeutics, based in Houston. The deal was reported on October 13, 2026. A clinical-stage oncology-focused cell therapy company. Alaunos Therapeutics is publicly traded (TCRT) and operates in Biotechnology.

When did Alaunos Therapeutics acquire Velaris Therapeutics?

Alaunos Therapeutics's acquisition of Velaris Therapeutics was reported on October 13, 2026. Alaunos Therapeutics, Inc. has successfully acquired Velaris Therapeutics. This acquisition enhances Alaunos's capabilities in developing cutting-edge therapies for cancer. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.

What does Velaris Therapeutics do?

Velaris Therapeutics is a biotechnology firm dedicated to developing unique treatment solutions for rare diseases. Their focus is on creating therapies that address significant unmet medical needs. It is privately held, operating in Biotechnology, and is based in Berat.

This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.